You are here

News

Coverage of the latest news and updates from the field of stem cells.

August 8, 2019

TOKYO (JP), August 2019 — The human liver is a vital organ involved in multiple functions.

August 8, 2019

SEATTLE, WA (US), August 2019 — Researchers at Fred Hutchinson Cancer Research Center have used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia.

August 5, 2019

YOKOHAMA (JP), August 2019 — Scientists have developed an efficient method of successfully generating hair growth in nude mice.

August 5, 2019

LONDON (UK), August 2019 — A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research published in 

August 2, 2019

CHICAGO, IL (US), July 2-19 — Researchers have discovered how the genetic defect in fragile X syndrome — a type of autism — delays production of neurons (nerve cells) at a critical time in the embryo's brain development.

August 2, 2019

OAKLAND, CA (US), July 2019 — The California Institute for Regenerative Medicine (CIRM) board has approved investing $19.7 million in four awards in its Translational Research program, which helps promising projects complete the testing needed to begin talking to the US Food and

August 2, 2019

STANFORD, CA (US), July 2019 — Researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.

August 1, 2019

OAKLAND, CA (US), July 2019 – A new clinical trial under way that is testing a therapy to treat brain metastases from breast cancers expressing high levels of a protein called HER2.  Brain metastases are tumors in the brain that have spread from the original site of the

August 1, 2019

LONDON (UK), July 2019 — Scientists have identified a new type of cell called a hepatobiliary hybrid progenitor (HHyP) that forms during our early development in the womb.

August 1, 2019

ROCHESTER, MN (US), July 2019 ― A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome (HLHS) through collecting, processing and injecting a

Pages